0000899243-22-023125.txt : 20220617 0000899243-22-023125.hdr.sgml : 20220617 20220617170650 ACCESSION NUMBER: 0000899243-22-023125 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220615 FILED AS OF DATE: 20220617 DATE AS OF CHANGE: 20220617 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Mattessich Antony C. CENTRAL INDEX KEY: 0001709900 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40971 FILM NUMBER: 221024886 MAIL ADDRESS: STREET 1: C/O OCULAR THERAPEUTIX, INC. STREET 2: 34 CROSBY DR., SUITE 105 CITY: BEDFORD STATE: MA ZIP: 01730 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aura Biosciences, Inc. CENTRAL INDEX KEY: 0001501796 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 320271970 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 85 BOLTON STREET CITY: CAMBRIDGE STATE: MA ZIP: 02140 BUSINESS PHONE: (617)500-8864 MAIL ADDRESS: STREET 1: 85 BOLTON STREET CITY: CAMBRIDGE STATE: MA ZIP: 02140 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-06-15 0 0001501796 Aura Biosciences, Inc. AURA 0001709900 Mattessich Antony C. C/O AURA BIOSCIENCES, INC. 85 BOLTON STREET CAMBRIDGE MA 02140 1 0 0 0 Stock Option (Right to Buy) 13.72 2022-06-15 4 A 0 16000 0.00 A 2032-06-15 Common Stock 16000 16000 D This stock option will vest and become exercisable in full upon the earlier to occur of (a) June 15, 2023 or (b) the next annual meeting of the Issuer's stockholders. /s/ Julie Feder, Attorney-in-fact 2022-06-17